Cenzhu Wang
Overview
Explore the profile of Cenzhu Wang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
152
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hou R, Wu X, Wang C, Fan H, Zhang Y, Wu H, et al.
Int J Oncol
. 2025 Feb;
66(4).
PMID: 40017131
Cancer is the second leading cause of death among humans worldwide. Despite remarkable improvements in cancer therapies, drug resistance remains a significant challenge. The tumor microenvironment (TME) is intimately associated...
2.
Cheng W, Wang C, Ma M, Zhou Y
Front Cell Dev Biol
. 2025 Feb;
13:1529901.
PMID: 39911324
Background: Diabetic kidney disease (DKD) is the leading risk factor for end-stage renal disease (ESRD). Hydroxyurea (HU), a sickle cell disease (SCD) drug approved by FDA, shows protective effect in...
3.
Liu M, Wang C, Hu Q, Wu X, Wang Q, Wang J, et al.
Transl Oncol
. 2025 Jan;
53:102287.
PMID: 39837060
Breast cancer is one of the most common cancers worldwide, 30-50 % of patients with advanced breast cancer develop brain metastasis, causing severe damage to their life quality. Due to...
4.
Liu J, Wang C, Jiang Y, Zhou Y, Chen L, Qian Z, et al.
Cancer Cell Int
. 2024 Jun;
24(1):205.
PMID: 38858701
The members of the classic B7 family regulate the immune microenvironment of several malignant tumors. However, the potential relationship between the B7 family and the breast cancer (BrCa) tumor immune...
5.
Li X, Tang L, Chen Q, Cheng X, Liu Y, Wang C, et al.
Chin Med J (Engl)
. 2022 Dec;
135(20):2436-2445.
PMID: 36583862
Background: Cancer immunotherapy has emerged as a promising strategy against triple-negative breast cancer (TNBC). One of the immunosuppressive pathways involves programmed cell death-1 (PD-1) and programmed cell death ligand-1 (PD-L1),...
6.
Circulating Tumor Cells and Breast Cancer Metastasis: From Enumeration to Somatic Mutational Profile
Zhu C, Xu J, Sun J, Cui S, Sun Y, Yu T, et al.
J Clin Med
. 2022 Oct;
11(20).
PMID: 36294386
Aims: This study investigates the association between circulating tumor cells (CTCs) and breast cancer metastasis. Methods: A retrospective study was conducted using patients with histologically confirmed breast cancer recruited from...
7.
Xu K, Wang R, Chen Q, Liu Y, Li X, Mao L, et al.
Acta Biochim Biophys Sin (Shanghai)
. 2022 Sep;
54(9):1336-1348.
PMID: 36148946
As an indicator of clinical prognosis, lymph node metastasis of breast cancer has drawn great attention. Many reports have revealed the characteristics of metastatic breast cancer cells, however, the effect...
8.
Wang C, Xu K, Deng F, Liu Y, Huang J, Wang R, et al.
Transl Cancer Res
. 2022 Feb;
10(5):2229-2246.
PMID: 35116541
Background: Breast cancer (BC) is one of the most common cancers worldwide and patients with lymph node metastasis always suffer from a worse prognosis. Tumor mutation burden (TMB) has been...
9.
Wang C, Xu K, Wang R, Han X, Tang J, Guan X
J Exp Clin Cancer Res
. 2021 Nov;
40(1):370.
PMID: 34801088
Breast cancer is one of the most-common female malignancies with a high risk of relapse and distant metastasis. The distant metastasis of breast cancer exhibits organotropism, including brain, lung, liver...
10.
Xu K, Wang R, Xie H, Hu L, Wang C, Xu J, et al.
Oncogenesis
. 2021 Oct;
10(10):66.
PMID: 34611125
Molecular mechanisms underlying breast cancer lymph node metastasis remain unclear. Using single-cell sequencing, we investigated the transcriptome profile of 96,796 single cells from 15 paired samples of primary tumors and...